Literature DB >> 35061085

Inflammasome activation, NLRP3 engagement and macrophage recruitment to tumor microenvironment are all required for Salmonella antitumor effect.

Jose Alejandro Chabalgoity1, María Moreno2, Amy Mónaco3, Sofía Chilibroste3, Lucía Yim3.   

Abstract

Salmonella-based cancer therapies show great potential in preclinical models, but for most cases the observed antitumor effect is transient. Understanding the basis of the antitumor efficacy might guide the design of improved strains that elicit long-lasting effects, paving the wave for clinical use.  Here, we deepened into the role of macrophages and inflammasome activation in the context of Salmonella anti-melanoma effect. We showed inflammasome activation in melanoma cells upon infection, which correlated with cell surface exposure of gasdermin-D (GSDM-D) and calreticulin (CRT) and High mobility group box 1 protein (HMGB-1) release, suggesting immunogenic cell death, particularly pyroptosis. Salmonella infection upregulated levels of Caspase-11 (Casp11) mRNA, but not Nlrp3 or Nlrc4 mRNA, the only described inflammasome receptors engaged by Salmonella, suggesting that non-canonical inflammasome activation could be occurring in melanoma cells. Intratumoral administration of Salmonella to melanoma-bearing mice elicited local inflammasome activation and interleukin-1β (IL-1β) production together with tumor growth retardation and extended survival in wild type but not Caspase-1/11 (Casp1/11) knockout mice despite similar levels of intratumoral IL-1β in the later. Salmonella antitumor activity was also suppressed in melanoma bearing Nlrp3 knockout mice. Salmonella induced macrophage recruitment to the tumor site and infiltrating cells exhibited inflammasome activation. Depletion experiments confirmed that macrophages are also essential for Salmonella anti-melanoma effect. Intratumoral macrophages showed a marked M2/M1 shift soon after treatment but this inflammatory profile is then lost, which could explain the transient effect of therapy.  All in all, our results highlight CASP-1/11 axis and macrophages as essential players in Salmonella-based cancer immunotherapy and suggest a possible target for future interventions.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Inflammasome; M2/M1 shift; Macrophage recruitment; Melanoma; Salmonella immunotherapy

Mesh:

Substances:

Year:  2022        PMID: 35061085     DOI: 10.1007/s00262-022-03148-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.630


  6 in total

1.  Tumor-targeted Salmonella as a novel anticancer vector.

Authors:  J M Pawelek; K B Low; D Bermudes
Journal:  Cancer Res       Date:  1997-10-15       Impact factor: 12.701

2.  A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.

Authors:  Chenguang Shen; Junyu Chen; Rui Li; Mengya Zhang; Guosong Wang; Svetlana Stegalkina; Limin Zhang; Jing Chen; Jianli Cao; Xingjian Bi; Stephen F Anderson; Timothy Alefantis; Minwei Zhang; Xiaoyang Cai; Kunyu Yang; Qingbing Zheng; Mujing Fang; Hai Yu; Wenxin Luo; Zizheng Zheng; Quan Yuan; Jun Zhang; James Wai-Kuo Shih; Harry Kleanthous; Honglin Chen; Yixin Chen; Ningshao Xia
Journal:  Sci Transl Med       Date:  2017-10-18       Impact factor: 17.956

3.  An obligatory anaerobic Salmonella typhimurium strain redirects M2 macrophages to the M1 phenotype.

Authors:  Mei Yang; Juan Xu; Qi Wang; An-Qin Zhang; Kun Wang
Journal:  Oncol Lett       Date:  2018-01-08       Impact factor: 2.967

4.  Role of inflammasomes in salmonella infection.

Authors:  Luigi Franchi
Journal:  Front Microbiol       Date:  2011-01-31       Impact factor: 5.640

Review 5.  New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.

Authors:  Qiujun Guo; Zhichao Jin; Yuan Yuan; Rui Liu; Tao Xu; Huamin Wei; Xinyao Xu; Shulin He; Shuntai Chen; Zhan Shi; Wei Hou; Baojin Hua
Journal:  J Immunol Res       Date:  2016-11-16       Impact factor: 4.818

6.  M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.

Authors:  Michal Hensler; Lenka Kasikova; Karel Fiser; Jana Rakova; Petr Skapa; Jan Laco; Tereza Lanickova; Ladislav Pecen; Iva Truxova; Sarka Vosahlikova; Irena Moserova; Ivan Praznovec; Vit Drochytek; Martina Rehackova; Tomas Brtnicky; Lukas Rob; Vladimir Benes; Jelena Pistolic; Ludek Sojka; Ales Ryska; Catherine Sautes-Fridman; Wolf Herve Fridman; Lorenzo Galluzzi; Radek Spisek; Jitka Fucikova
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

  6 in total
  3 in total

1.  Intratumoral injection of schwannoma with attenuated Salmonella typhimurium induces antitumor immunity and controls tumor growth.

Authors:  Sherif G Ahmed; Giulia Oliva; Manlin Shao; Xinhui Wang; John J Mekalanos; Gary J Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-08       Impact factor: 12.779

2.  Salmonella-induced immune response reduces recurrence and tumor dissemination in preclinical melanoma model.

Authors:  Amy Mónaco; María C Plata; Sofía Chilibroste; Magdalena Vola; Jose A Chabalgoity; María Moreno
Journal:  Curr Res Immunol       Date:  2022-08-18

Review 3.  Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy.

Authors:  Elayne Irene Becerra-Báez; Sergio Enrique Meza-Toledo; Paola Muñoz-López; Luis Fernando Flores-Martínez; Karla Fraga-Pérez; Kevin Jorge Magaño-Bocanegra; Uriel Juárez-Hernández; Armando Alfredo Mateos-Chávez; Rosendo Luria-Pérez
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.